Cell Therapy News/Articles, page-8147

Thanks so much for finding & posting this most recent media clip (Jan 8 2021) @RUWM. I copied below two paragraphs from the article.

Your post is a great tonic for my ongoing battle with patience . I hope Remestemcel-L can continue to provide life-saving treatment for this critically ill children.

She said his heart condition led them to try the new treatment, adding in order to qualify for remestemcel-L treatment, there must be evidence the patient’s heart is not functioning properly. She said in both children’s cases, the results were very promising.

“Within a couple days of giving them the investigational treatment, they were ready to go home. It was just truly remarkable,” she said. “What is special about this product is that it not only treats the inflammation, but there is evidence that it actually goes to the site of the damage in the heart and the blood vessels and repairs them.”

Oh & do you think Novartis would be interested in this?!